Longevity Health Holdings, Inc. reported significant financial developments in its recent 10-K filing for the fiscal year ending December 31, 2025. The company generated gross sales of $2.15 million, a substantial increase from $90,829 in the previous year, primarily driven by the acquisition of Elevai Skincare. Net sales reached $1.91 million, reflecting a 3,701% increase compared to $50,318 in 2024. Despite this growth, the company reported a net loss of $6.91 million, an improvement from the $10.65 million loss in the prior year, indicating a 35% reduction in losses.
The filing highlighted several strategic developments, including the completion of the Elevai Acquisition in January 2025, which significantly contributed to the company's revenue. Additionally, the company underwent a leadership transition, appointing Janakiram Ajjarapu as the new Chairman and CEO, following the departure of Rajiv Shukla. The company also closed a private placement in March 2026, raising approximately $200,000 through the sale of shares, which is part of its ongoing efforts to secure additional capital.
Operationally, Longevity Health Holdings reported a total of 1,781,738 shares outstanding as of December 31, 2025, following a reverse stock split in May 2025. The company has focused on expanding its product offerings, launching new skincare products and a scalp serum, while also emphasizing its commitment to quality control and compliance with regulatory standards. The company’s workforce remained stable, with ten full-time employees as of March 2026.
Looking ahead, the company faces challenges related to its liquidity, as it reported negative working capital of $5.97 million and negative cash flow from operations of $3.33 million for the year. Management has expressed substantial doubt about the company's ability to continue as a going concern without raising additional capital. The company plans to explore further financing options and strategic acquisitions to enhance its cash flow and operational sustainability. The filing underscores the importance of market acceptance of its products and the need for effective management of operational expenses to achieve profitability in the future.
About Longevity Health Holdings, Inc.
Longevity Health Holdings, Inc. develops bio-aesthetic and regenerative products, including skincare, haircare, and tissue healing solutions. Its core offerings leverage proprietary biologics, exosomes, and platelet-rich plasma to promote skin rejuvenation, hair growth, and tissue repair. Serving medical and consumer markets, the company emphasizes safety, innovation, and scientific validation, with a focus on professional channels and direct-to-consumer sales in the growing aesthetic industry.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.